Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 302 | 973 | -17,131 | 9,217 | 5,090 |
| Gross Profit | 302 | 973 | -17,131 | 9,217 | 5,090 |
| Operating Expenses | 96,286 | 9,515 | 1,494 | 13,685 | 11,838 |
| Operating Income | -95,984 | -8,542 | -18,625 | -4,468 | -6,748 |
| Other Income | 1,774 | 365 | 527 | 613 | 623 |
| Pre-tax Income | -94,210 | -8,177 | -18,098 | -3,855 | -6,125 |
| Income Tax | N/A | N/A | 7 | -32 | 40 |
| Net Income Continuous | -94,210 | -8,177 | -18,105 | -3,823 | -6,165 |
| Net Income Discontinuous | 3,001 | -2,149 | 14,892 | -5,284 | -7,459 |
| Net Income | $-91,209 | $-10,326 | $-3,213 | $-9,107 | $-13,624 |
| EPS Basic Total Ops | -19.99 | -2.28 | -0.81 | -2.02 | -3.02 |
| EPS Basic Continuous Ops | -20.65 | -1.80 | -4.29 | -0.85 | -1.37 |
| EPS Basic Discontinuous Ops | 0.66 | -0.47 | 3.31 | -1.17 | -1.65 |
| EPS Diluted Total Ops | -19.99 | -2.28 | -0.81 | -2.02 | -3.02 |
| EPS Diluted Continuous Ops | -20.65 | -1.80 | -4.12 | -0.85 | -1.37 |
| EPS Diluted Discontinuous Ops | 0.66 | -0.47 | 3.31 | -1.17 | -1.65 |
| EPS Diluted Before Non-Recurring Items | -2.05 | -2.28 | -0.80 | N/A | N/A |
| EBITDA(a) | $-95,759 | $-8,470 | $-18,562 | $-4,433 | $-7,158 |